XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Allocation of recognized period costs
The following table summarizes the allocation of stock-based compensation in the condensed consolidated statements of operations (in thousands):
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2021202220212022
Delivery costs$521 $914 $830 $1,496 
Sales and marketing expense3,655 3,633 6,087 7,337 
Research and development expense2,448 4,247 3,962 7,451 
General and administration expense6,713 4,048 9,706 10,143 
Total stock-based compensation expense$13,337 $12,842 $20,585 $26,427 
Summary of common stock option activity
Options to purchase shares of common stock generally vest over four years and expire 10 years following the date of grant. The following table summarizes changes in common stock options:
Shares
(in thousands)
Weighted-Average Exercise PriceWeighted Average Contractual Life (in years)
Aggregate Intrinsic Value(1)
(in thousands)
Options outstanding — December 31, 2021406 $25.17 
Exercised(16)23.77 $335 
Options outstanding and exercisable — June 30, 2022389 $25.22 4.35$543 
(1)For options exercised during the period, the aggregate intrinsic value represents the total pre-tax intrinsic value received by option holders based on the closing price of our common stock as reported on the Nasdaq Global Market on the exercise date. For options outstanding and exercisable at June 30, 2022, the aggregate intrinsic value represents the total pre-tax intrinsic value based on the $22.31 per share closing price of our common stock as reported on the Nasdaq Global Market on June 30, 2022, that would have been received by option holders had all in-the-money options been exercised on that date.
The following table summarizes changes in common stock options from the Bridg acquisition:
Shares
(in thousands)
Weighted-Average Exercise PriceWeighted Average Contractual Life (in years)
Aggregate Intrinsic Value
(in thousands)
(1)
Options outstanding — December 31, 202118 $8.45 
Exercised(2)8.49 86 
Forfeited(11)8.37 
Options outstanding — June 30, 20228.73 8.8547 
Exercisable — June 30, 2022$8.75 
(1)For options exercised during the period, the aggregate intrinsic value represents the total pre-tax intrinsic value received by option holders based on the closing price of our common stock as reported on the Nasdaq Global Market on the exercise date. For options outstanding and exercisable at June 30, 2022, the aggregate intrinsic value represents the total pre-tax intrinsic value based on the $22.31 per share closing price of our common stock as reported on the Nasdaq Global Market on June 30, 2022, that would have been received by option holders had all in-the-money options been exercised on that date.
The following table summarizes changes in common stock options from the Dosh acquisition:
Shares
(in thousands)
Weighted-Average Exercise PriceWeighted Average Contractual Life (in years)
Aggregate Intrinsic Value
(in thousands)
(1)
Options outstanding — December 31, 202130 $3.06 
Exercised(5)3.06 $221 
Forfeited(4)3.06 
Options outstanding — June 30, 202221 3.06 8.68$395 
Exercisable — June 30, 2022$3.06 
(1)For options exercised during the period, the aggregate intrinsic value represents the total pre-tax intrinsic value received by option holders based on the closing price of our common stock as reported on the Nasdaq Global Market on the exercise date. For options outstanding and exercisable at June 30, 2022, the aggregate intrinsic value represents the total pre-tax intrinsic value based on the $22.31 per share closing price of our common stock as reported on the Nasdaq Global Market on June 30, 2022, that would have been received by option holders had all in-the-money options been exercised on that date.
Summary of RSU activity
We grant restricted stock units ("RSUs") to employees and our non-employee directors. The following table summarizes changes in RSUs, inclusive of performance-based RSUs:
Shares
(in thousands)
Weighted-Average Grant Date Fair ValueWeighted-Average Remaining Contractual Term (in years)Unamortized Compensation Costs
(in thousands)
Unvested — December 31, 20212,294 $60.58 
Granted2,072 51.90 
Vested(504)51.95 
Forfeited(281)73.54 
Unvested — June 30, 20223,581 $55.75 3.00$166,750